Back to today’s briefing

Story perspectives

23andMe Files for Bankruptcy, CEO Resigns Amid Cuts

3/24/2025

36 7

Summary

Story summary

Genetic testing pioneer 23andMe has taken a dramatic turn, filing for Chapter 11 bankruptcy to pave the way for a sale after enduring years of financial turmoil. Co-founder and CEO Anne Wojcicki has stepped down as the company, now valued at $50 million, slashes 40% of its workforce while securing $35 million to keep operations afloat during this critical transition.

History

Historical Context

23andMe's bankruptcy echoes the fate of other tech startups that soared and then plummeted, like Theranos. Founded in 2006, it initially thrived on genetic innovation but faced scrutiny over data privacy and profitability. This decline reflects broader trends in Silicon Valley, where hype often overshadows sustainable growth.

1 of 2

Story summary

Genetic testing pioneer 23andMe has taken a dramatic turn, filing for Chapter 11 bankruptcy to pave the way for a sale after enduring years of financial turmoil. Co-founder and CEO Anne Wojcicki has stepped down as the company, now valued at $50 million, slashes 40% of its workforce while securing $35 million to keep operations afloat during this critical transition.

1 / 2